Diabetes risk factors develop earlier in women than men
Washington, Feb 20 (Xinhua) The ‘diabetes clock’ may start ticking in women years in advance of a medical diagnosis of the disease, according to a new research.
Epidemiologists at the University at Buffalo in New York have found that newly identified risk factors for diabetes found in the blood, such as markers of endothelial dysfunction, chronic sub-acute inflammation and blood clotting factors, are present early on in women who eventually progress from normal glucose status to the pre-diabetic condition.
‘This is one of the first reports to show that otherwise healthy women are more likely than men to show elevated levels of endothelial factors and other markers of progression to pre-diabetes,’ said lead author Richard Donahue. Source
UA to study if fish oil helps prevent diabetes
University of Arizona researchers will study the effectiveness of fish oil in preventing or reversing the effects of Type 2 diabetes, thanks to a grant from the Tohono O’odham Nation.
The grant was given to the Steele Children’s Research Center to study how Omega-3 fatty acids in fish oil can prevent or delay the disease.
“It is well known that Native Americans are genetically susceptible to Type 2 diabetes,” said Sherman Garver, associate research professor with the department of pediatrics at UA. Source
The Diabetes Blog has this post: Omega-3 effects on type 2 to be studied
Glucose RapidSpray Available in the US
The company making oral insulin a reality is distributing a teaser product to give you a hands-on example of the efficacy, ease and convenience their drug delivery system offers. Feast your buccal cavity on Glucose RapidSpray! The reality of oral-insulin is coming soon to the US - but its sugar stabilizing sister is here today! Source: The Diabetes Blog
Lilly Introduces World’s First Digital Insulin Pen With Memory
Feb. 22 /PRNewswire-FirstCall/ — Eli Lilly and Company today announced the launch of the first insulin pen with memory, HumaPen(R) MEMOIR(TM), to help simplify the daily management of diabetes.
MEMOIR is designed to meet the needs of people with diabetes who take several shots of mealtime insulin each day. It presents sophisticated technology and features in a consumer-friendly “push-to-know” digital display that allows patients to record and review their last 16 insulin doses, including the priming doses.
Many insulin users need multiple shots per day, so the ability to record doses and the time of the dose may help simplify the daily management of diabetes. This is especially important for both patients and physicians when developing a diabetes treatment plan that utilizes accurate recording of mealtime doses. MEMOIR is now available by prescription in pharmacies nationwide for use with Humalog(R) (insulin lispro injection [rDNA origin]), the most-prescribed mealtime insulin in the United States. Source
—
Resources:
dLife; About Diabetes.com; American Diabetes Association
Technorati Tags:
Diabetes; Health News
February 27th, 2007 at 3:00 pm
This week’s trackposting with OTA led me here. Just finished strolling around the blog and read the “abouts”. Imagine that, normal people. Thanks for the OTA exposure and for building a good blog.
BTW, I commented to this post as someone in my family has type II and the comments were empty. Have a good whatever.